(3) The Part B IPI Model

The Certara Market Access Channel

In this episode, we're dissecting the US Administrations initiative to overhaul Medicare Part B drug reimbursement, incorporating international reference pricing. Experts on call Ulrich Neumann, Sr. Director, US Access [e-mail] Additional notes: - We referenced the Implications of Pricing on Innovation which is thoroughly discussed in this article by USC's Darius Lakdawalla Lakdawalla, Darius N. 2018. "Economics of the Pharmaceutical Industry." Journal of Economic Literature, 56 (2): 397-449. DOI: 10.1257/jel.20161327 --- Send in a voice message: https://podcasters.spotify.com/pod/show/market-access/message